AMGN - Amgen Inc Revenue Growth Rate YoY (Last Twelve Months)

Amgen Inc. relies on a balanced portfolio of drugs to combat cancer and cardiac pathologies. The company's TTM annual revenue growth rate confirms this stability, where 8.60 becomes the new value for this metric. Growth is supported by unique expertise in developing complex biologics and a moderate use of external contractors while maintaining in-house production.
Amgen Inc (AMGN) - metric breakdowns and financial figures

This indicator measures the percentage change in total revenue over the last 12 months relative to the same period last year, allowing for an assessment of business scaling rates. The ability of Amgen Inc. (AMGN) to combine the outsourcing of clinical trials with in-house production of bulk drug substances minimizes operational risks, which is directly reflected in the revenue trend over four quarters year-over-year.